Category
Healthcare
Pharmaceutical companies, biotechnology, healthcare services, and medical device manufacturers. Drug approvals, clinical trials, and sector dynamics.
Healthcare
MDT Q3 2026: filings, holdings, and macro context
Healthcare
CVS Q3 2026 update — filings and holdings
Healthcare
GILD Q3 2026: filings, holdings, and macro context
Healthcare
JNJ Q3 2026: filings, holdings, and macro context
Healthcare
ABBV Q3 2026: filings, holdings, and macro context
Healthcare
AMGN Q3 2026: filings, holdings, and macro context
Healthcare
PFE Q3 2026 update — filings and holdings
Healthcare
MRK Q3 2026: filings, holdings, and macro context
Healthcare
LLY Q3 2026 update — filings and holdings
Healthcare
UNH Q2 2026: filings, holdings, and macro context
Healthcare
MDT Q3 2026: filings, holdings, and macro context
Healthcare
CVS Q3 2026 update — filings and holdings
Healthcare
GILD Q3 2026 update — filings and holdings
Healthcare
ABT Q3 2026 update — filings and holdings
Healthcare
JNJ Q3 2026: filings, holdings, and macro context
Healthcare
ABBV Q3 2026 update — filings and holdings
Healthcare
AMGN Q3 2026: filings, holdings, and macro context
Healthcare
MRK Q3 2026: filings, holdings, and macro context
Healthcare
LLY Q3 2026 update — filings and holdings
Healthcare
UNH Q2 2026 update — filings and holdings
Healthcare
Nanexa shares surge 150% after $1bn Novo Nordisk licensing deal
Nanexa shares rose more than 150% in a single session after the Stockholm-listed microcap announced a licensing agreement with Novo Nordisk valued at over $1 billion, covering injectable formulations and delivery systems.
Healthcare
MDT Q3 2026: filings, holdings, and macro context
Healthcare
CVS Q3 2026: filings, holdings, and macro context
Healthcare